Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare Conference
September 28 2018 - 7:30AM
Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today
announced that Dr. Claus Bo Svendsen, the Company’s Chief
Executive Officer, will participate in the Ladenburg Thalmann
2018 Healthcare Conference in New York, NY. Dr. Svendsen
will present a corporate update on Tuesday, October 2,
2018 at 11:30AM ET and will be available for one-on-one
meetings.
Investors and other interested parties may
access a live audio webcast of Dr. Svendsen’s conference
presentation by visiting the investor page on the Company’s website
(ir.forward-pharma.com). The audio replay will be available via our
website for 90 days following the presentation.
About Forward Pharma:
Forward Pharma A/S is a Danish biopharmaceutical
company that commenced development in 2005 of FP187®, a proprietary
formulation of DMF for the treatment of inflammatory and
neurological indications. The Company granted to Biogen an
irrevocable license to all of its IP through the Settlement and
License Agreement and received from Biogen a non-refundable cash
fee of $1.25 billion in February 2017, with the return of EUR 917.7
million to shareholders through a Capital Reduction in September
2017. The Company has the opportunity to receive royalties from
Biogen on net sales of Tecfidera® or other DMF products for MS,
dependent on, among other things, successfully appealing the U.S.
interference and a favorable outcome in Europe with respect to the
EP2801355 Patent Opposition Proceedings, including any appeal
thereto.
The principal executive offices are located at
Østergade 24A, 1st Floor, 1100 Copenhagen K, Denmark and our
American Depositary Shares are publicly traded on the Nasdaq Stock
Market (FWP). For more information about the Company, please visit
our website at http://www.forward-pharma.com.
Forward Pharma A/S Investor Relations
Contact:
Forward Pharma A/S Claus Bo Svendsen, MD, PhD
Chief Executive Officer Investor Relations
investors@forward-pharma.com
Solebury Trout John
Grazianojgraziano@troutgroup.com +1 (646) 378 2942
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Forward Pharma AS (NASDAQ:FWP)
Historical Stock Chart
From Apr 2023 to Apr 2024